. We previously reported the functional and physical interactions between TLR4 and PAR 2 . We have extended these findings herein by showing the cooperation between PAR 2 and TLR2, TLR3, or TLR4 for activation of nuclear factor-B-dependent signaling in mucosal EC lines. In contrast, activation of PAR 2 negatively regulated TLR3-dependent antiviral pathway, blunting the expression of TLR3 / interferon regulatory factor-3 (IRF-3)-driven genes, as well as activation of IRF-3 and STAT1. Consistent with these in vitro observations, PAR 2 − / − and TLR4 − / − mice, which were refractory to footpad edema induced by PAR 2 agonist peptide, were protected from mouse-adapted H1N1 influenza A virus-induced lethality when compared to wild-type (WT) mice. These data support and extend our recently described, novel model of PAR 2 -TLR4 " receptor cooperativity " and highlight the complexity of signaling integration between heterologous innate immune biosensors.
INTRODUCTION
Pathogen recognition is a critical function of innate immunity. Distinct germline-encoded pattern-recognition receptors (PRRs) expressed on innate immune cells detect microbial structures and virulence factors, including microbial proteinases (reviewed in Gribar et al. 1 and Vroling et al. 2 ). Toll-like receptors (TLRs) and proteinase-activated receptors (PARs) represent two structurally distinct classes of transmembrane receptors that have key roles in the innate immune response to pathogens. For example, influenza A virus infection activates multiple PRRs, including TLR3, 3,4 but also generates extracellular proteinases 5, 6 that could activate PARs.
" Classical " PRRs sense pathogen-associated molecular patterns (PAMPs), structural molecular motifs that are evolutionarily conserved and shared among members of a given microbial class (reviewed in Janeway and Medzhitov, 7 Akira and Takeda, 8 and Akira et al. 9 ). In mouse and man, the TLRs represent a family of >10 single-transmembrane classical PRRs that detect chemically conserved microbial components, for example, lipopolysaccharide (LPS), lipopeptides, and RNA. Ligand engagement of TLR N-terminal ectodomains induces receptor dimerization that brings the intracytoplasmic " Toll / interleukin-1 (IL-1) receptor resistance " (TIR) domains into close proximity. This interaction facilitates subsequent recruitment of TIR-domain-containing adapter proteins, kinases, and other signaling molecules to the " signaling platform " generated by the interacting TIR domains of the TLR dimer.
The innate immune system also senses proteolytic enzymes generated during infection through a family of " nonclassical " PRRs, for example, PARs. The PARs are a family of four 7-transmembrane, G protein-coupled receptors (7-TM GPCRs) that detect serine proteinases derived from pathogens and the host (reviewed in Steinhoff et al. 10 and Ramachandran and Hollenberg 11 ). PAR 1 , PAR 3 , and PAR 4 are activated by thrombin; PAR 2 mediates the cellular effects of trypsin and trypsin-like enzymes, including several microbial proteinases.
PAR-activating enzymes cleave each PAR irreversibly at a specific site in the extracellular N-terminus to expose a tethered neo-ligand that binds to the second extracellular loop (ECL2) of each GPCR to trigger receptor activation. In this sense, the PARs function as a novel class of nonclassical PRRs that might serve as additional pathogen / tissue damage biosensors. Synthetic PAR agonist peptides (APs), corresponding to the hexapeptide sequences of the tethered neo-ligands of PAR 1 , PAR 2 , and PAR 4 , activate the native, uncleaved PARs nonenzymatically by binding directly to the corresponding PAR ECL2 to mediate signaling.
Proteinase-activated receptors and TLRs are distributed ubiquitously, yet strategically, in the body. Of the four PARs, PAR 2 has been most extensively studied with respect to the inflammatory response to microbial exposure. PAR 2 is expressed highly in the respiratory and gastrointestinal (GI) tracts on epithelial cells (ECs), endothelial cells, macrophages, and dendritic cells (DCs) (reviewed in Steinhoff et al. 10 and Ramachandran and Hollenberg 11 ). Exposure of human ECs to proteinases purified from certain pathogens activates PAR 2 to induce antimicrobial and inflammatory responses. 12 -15 In mice, PAR 2 deficiency reduces clearance of bacterial, parasitic, and fungal infections. 16 -18 Similar to PARs, TLRs are also expressed on ECs, endothelial cells, macrophages, and DCs in the airway and GI tract. In general, TLR2 and TLR4 recognize Gram-positive and Gram-negative bacteria, respectively; TLR3 detects double-stranded RNA (dsRNA) from viruses (reviewed in Akira and Takeda 8 ). Experimentally, TLR2 is activated by synthetic di-or triacylated lipopeptides that mimic bacterial cell wall constituents. TLR3 is stimulated by the synthetic dsRNA analog, polyinosine -polycytidylic acid (poly I:C). TLR4 is triggered by Gram-negative bacterial LPS. Signals originating from independently engaged, heterologous receptors may converge synergistically or antagonistically to modify cellular responses to different exogenous stimuli (reviewed in Trinchieri and Sher 19 and O ' Neill 20 ). PAR 2 activation delivers intracellular signals that intersect with TLR / IL-1R signaling pathways. 21 -24 We reported previously that PAR 2 AP augmented LPS-induced IL-8 secretion synergistically in SW620 human colonic ECs. 23 Our studies in HEK293T cells transfected with PAR 2 and / or TLR4 revealed a novel mechanism of " receptor cooperativity " in which PAR 2 AP-induced NF-B activation was synergistically enhanced by TLR4 coexpression. 23 These findings were strengthened by the observation that PAR 2 AP-induced NF-B-dependent IL-1 mRNA expression in TLR4 − / − macrophages was diminished. 23 Moreover, an AP-dependent, physical interaction between PAR 2 and TLR4 was shown in HEK293T cells by co-immunoprecipitation. 23 Given that TLRs and PARs are concurrently present on mucosal ECs (reviewed in Vroling et al. 2 ), we hypothesized that intracellular signaling pathways utilized by TLRs and PAR 2 would converge either cooperatively or non-cooperatively when co-engaged. As the mucosal epithelium is the frontline innate immune barrier of the respiratory and GI tracts, we analyzed lung (A549) and colonic (SW620) ECs for responsiveness to stimulation of PAR 2 and / or TLRs. Specifically, cellular responses to agonists of TLR2, TLR3, or TLR4 were examined to determine the potential effects of PAR 2 activation on the inflammatory responses associated with bacterial and viral infections in mucosal ECs. Cooperation between PAR 2 and TLR2, TLR3, or TLR4 for nuclear factor-B (NF-B)-dependent IL-8 mRNA induction was observed. However, our data also revealed a novel role for PAR 2 in the negative regulation of TLR3 antiviral pathway, leading to reduced expression of TLR3-, interferon (IFN) regulatory factor-3 (IRF-3)-driven genes, and diminished activation of IRF-3 and signal transducer and activator of transcription 1 (STAT1). In vivo , both PAR 2 − / − and TLR4 − / − mice were highly refractory to footpad edema induced by PAR 2 AP, and less susceptible to lethality following intranasal infection with a mouse-adapted H1N1 influenza A virus than wild-type (WT) C57BL / 6J mice. Collectively, this study highlights the complexity of signaling integration between heterologous innate immune biosensors that result in modulation of host inflammatory responses.
RESULTS
We reported recently that PAR 2 AP synergized with the TLR4 agonist, LPS, to enhance IL-8 secretion in SW620 human colonic ECs. 23 As PAR 2 is expressed highly and strategically on ECs of the respiratory and GI tracts, we postulated that PAR 2 might function as a novel, nonclassical PRR. We also hypothesized that cross talk between the two heterologous PRR classes, that is, PAR 2 and TLR2, 3, and 4, would modulate the inflammatory response.
PAR 2 AP responsiveness in human mucosal EC lines
Human lung (A549) and colonic (SW620) ECs were examined for responsiveness to PAR 2 AP. Both responded rapidly to PAR 2 AP with IL-8 mRNA induction that peaked rapidly at 0.5 -1 h after stimulation ( Figure 1a ) ; SW620 ECs responded similarly, but somewhat less robustly than A549 ECs. PAR 2 AP-treated A549 ECs also expressed a broader array of proinflammatory mediator genes examined, for example, MIP-3 , tumor necrosis factor-(TNF-), IL-6, IL-8, MIP-2 , MCP-1, and COX-2 ( Figure 1b ) than SW620 ECs (data not shown). A549 and SW620 ECs responded to PAR 2 AP with peak AP activities at ~ 100 vs . ~ 300 m , respectively ( Figure 1c ) . A control, reverse peptide (RP) was inactive in both cell lines.
Cooperative PAR 2 -TLR signaling integration in human mucosal EC lines A549 and SW620 ECs were next examined for responsiveness to TLR2, TLR3, or TLR4 agonists, that is, Pam2CSK4 (or P2C), poly I:C, or LPS, respectively, in the absence or presence of PAR 2 AP. In both EC lines, PAR 2 AP enhanced IL-8 mRNA expression induced by these TLR agonists ( Figure 2 ); a control RP had no effect. In A549 ECs, the effect of concurrent PAR 2 AP and LPS co-stimulation on IL-8 mRNA expression was additive ( Figure  2a ). However, in SW620 ECs, PAR 2 AP potentiated LPS-induced IL-8 mRNA synergistically ( Figure 2b ). As for PAR 2 and TLR2, cooperative signaling for IL-8 mRNA induction was detected in both EC lines ( Figure 2 ). In addition, PAR 2 AP, together with the TLR3 agonist, poly I:C, induced robust, synergistic augmentation of IL-8 mRNA levels in both EC lines ( Figure 2 ).
Cooperative and non-cooperative PAR 2 -TLR3 signaling integration
As the synergy between PAR 2 and TLR3 was the strongest observed for any of the agonist combinations tested, we examined PAR 2 -TLR3 signaling interactions further. Poly I: C stimulates MyD88-independent signaling by recruiting the adapter protein, TRIF, to the TLR3 dimer. Although MyD88-dependent signaling is predominantly associated with NF-B activation, TRIF-dependent signaling results in the activation of IFN regulatory factor-3 (IRF-3) and delayed NF-B activation (reviewed in Akira and Takeda 8 and Akira et al. 9 ). Although NF-B is most often associated with the induction of proinflammatory cytokines and chemokines, for example, IL-8 and MIP-3 , IRF-3 is a potent transcriptional activator of many MyD88-independent genes, including IFN-, IP-10, and RANTES. 25, 26 In both EC lines, PAR 2 AP induced mRNA expression of IL-8 and MIP-3 , but did not stimulate the expression of IFN-, IP-10, or RANTES mRNAs ( ( Figure 4 ) , 26, 28 and the delayed induction kinetics reflects its IFN-dependence. 26 Consistent with its inhibitory effect on poly I:C-induced IFN-gene expression, PAR 2 AP also inhibited poly I:C-induced TLR3 mRNA expression ( Figure 4 ). Kinetic analysis of SW620 ECs stimulated with PAR 2 AP and / or poly I:C yielded similar results (data not shown). In contrast to its effects on poly I:C-induced IFN-, IP-10, RANTES, and TLR3 mRNAs in A549 ECs, PAR 2 AP enhanced mRNA expression of other TLR3-driven, NF-B-regulated genes, that is, MCP-1, MIP-2 , TNF-, IL-6, and IL-1 (data not shown). Consistent with the mRNA data, PAR 2 AP augmented poly I:C-induced IL-8 and MIP-3 protein production synergistically, but suppressed poly I: C-induced IP-10 and RANTES secretion significantly in A549 ECs ( Figure 5 ). 
PAR 2 AP differentially modulates TLR3-mediated activation of NF-B and IRF-3
Consistent with the observation that the NF-B-responsive genes, for example, IL-8 and MIP-3 , were significantly upregulated by PAR 2 and TLR3 co-stimulation, NF-B p65 activation (phospho-Ser536) was enhanced in A549 ECs co-stimulated with AP and poly I:C vs . AP or poly I:C alone ( Figure 6a ). This observation was supported by a significant reduction in the levels of the negative regulator of NF-B, I B ( Figure 6b ). In contrast to augmented NF-B activation, PAR 2 AP downregulated poly I:C-induced IRF-3 activation (phospho-Ser396) significantly ( Figure 6c ). Total IRF-3 levels were unaffected ( Figures 6a -c ). Experiments in HEK293T cells transiently transfected with PAR 2 , TLR3, and luciferase reporter constructs driven by promoters having either interferon-stimulated response element (ISRE) or NF-B binding sites showed similar results: PAR 2 AP co-stimulation inhibited poly I:C-induced ISRE-luciferase activity, whereas AP and poly I:C co-treatments induced higher NF-B-luciferase reporter activity than AP or poly I:C alone (data not shown).
PAR 2 AP suppresses TLR3-induced STAT1 activation
Poly I:C triggers the TLR3 / IRF-3 pathway to induce the expression of IFN-that then binds to the type I interferon-/ receptor (IFN-/ β R), 25 -27 resulting in the activation of several transcription factors, including STAT1. As PAR 2 AP suppressed poly I:C-induced IRF-3 activation and mRNA expression of IRF-3-dependent genes, including IFN-, we predicted that AP would also suppress poly I:C-induced STAT1 activation. In A549 ECs, STAT1 Tyr701 phosphorylation (p-STAT1) was prominently induced at ~ 3 h after stimulation with poly I:C, but not with PAR 2 AP at any time point examined; however, AP significantly inhibited p-STAT1 levels in poly I:C-treated ECs ( Figure 6d ). Total STAT1 levels were unaffected. Together, these data support the finding that PAR 2 engagement can simultaneously augment TLR3-driven NF-B activation while inhibiting As PAR 2 activation inhibited the TLR3 / IRF-3 antiviral pathway in mucosal ECs, we hypothesized that PAR 2 − / − mice would exhibit a de-repressed TLR3 / IRF-3-mediated antiviral response and, thus, would exhibit increased protection against virus infection. Influenza A virus infection activates multiple PRRs, including MDA-5, RIG-I, and TLR3, 3,4 but also generates significant tissue damage that produces extracellular proteinases, 5,6 including elastase, 5 that could activate PAR 2 (reviewed in Vroling et al. ( Figure 7a ). At 600 p.f.u., all mice from both strains succumbed equally (data not shown). We reasoned that if PAR 2 − / − mice were resistant to influenza virus-induced lethality secondary to a de-repressed TLR3 / IRF-3 / IFN--mediated antiviral response, IFN-− / − mice would exhibit the opposite phenotype. Although most of the PAR 2 − / − mice survived the influenza infection (200 p.f.u.) vs . WT mice, all the IFN-− / − mice died ( Figure 7b ). Taken together, these in vivo data support our observations in EC lines that PAR 2 activation inhibits the antiviral response induced by innate immune biosensors, such as TLR3. The absence of PAR 2 conferred a protective phenotype on influenza-infected mice. Previously, we showed receptor cooperativity between PAR 2 and TLR4 in vitro . 23 In HEK293T transfectants, PAR 2 engagement by its AP resulted in NF-B activation that was synergistically enhanced by the coexpression of TLR4. TLR4-mediated enhancement of PAR 2 signaling was MyD88 dependent, whereas PAR 2 signaling in the absence of TLR4 was TRIF dependent. 23 Conversely, PAR 2 AP-treated TLR4 − / − macrophages exhibited significantly diminished expression of NF-B-dependent IL-1 mRNA vs. WT macrophages. In the HEK293T transfection system, PAR 2 AP induced a physical association between PAR 2 and TLR4. 23 We concluded from our earlier study that optimal PAR 2 signaling leading to NF-B activation occurs when in complex with TLR4 and its adapter protein, MyD88. 23 Given that optimal PAR 2 signaling requires TLR4, 23 and as PAR 2 − / − mice were resistant to influenza-induced lethality, we hypothesized that TLR4 − / − mice would be similarly protected. Similar to PAR 2 − / − mice, most of the TLR4 − / − mice survived H1N1 influenza A virus infection, under conditions in which most of the WT mice died ( Figure 7c ).
TLR4 contributes to PAR 2 -mediated inflammation in vivo
To test further the hypothesis that PAR 2 -TLR4 receptor cooperativity occurs in vivo , we also used a well-characterized footpad edema model. 29 Injection of PAR 2 AP, but not saline or an inactive, control (reverse) peptide (RP), into the hind footpads of WT C57BL / 6J mice rapidly induced edema that peaked at 1 h ( Figure 8 ). Neither PAR 2 AP nor RP induced footpad edema in PAR 2 − / − mice ( Figure 8a ). Compared to the WT response, PAR 2 AP-induced footpad edema was significantly diminished in both TLR4 − / − and MyD88 − / − mice ( Figures 8a  and b ) . Together, these in vivo data further support our recently described novel model of PAR 2 -TLR4 receptor cooperativity 23 in which optimal PAR 2 signaling leading to an inflammatory response requires TLR4 and MyD88.
DISCUSSION
Signaling pathways coordinately triggered by distinct innate immune PRRs on activation by microbial components, for example, PAMPs, proteinases, have the potential to synergize with or antagonize one another to modulate an inflammatory response to infection. Results from our recent study showed that PAR 2 and TLR4 synergized in vitro to augment a MyD88-mediated, NF-B-dependent inflammatory response. 23 In this study, we have extended these original observations by studying signaling interactions between the classical PRRs, that is, TLR2, TLR3, and TLR4, and a nonclassical PRR, that is, PAR 2 , in A549 and SW620 ECs derived from human respiratory and colonic mucosa, respectively. Our data presented herein support the conclusion that PAR 2 -TLR signaling integration drives " customized " inflammatory responses to combinatorial " danger " stimuli from the environment. We observed cooperative signaling convergence between PAR 2 and TLR2, TLR3, or TLR4 for mRNA induction of NF-B-dependent IL-8, a potent neutrophil chemoattractant; cooperation between PAR 2 and TLR3 was highly synergistic. We also showed, for the first time, that PAR 2 coactivation led to differential signaling outcomes in TLR3-stimulated mucosal ECs. We revealed a novel role for PAR 2 in the negative regulation of TLR / IRF-3 antiviral pathway, leading to reduced expression of TLR3-, IRF-3-driven genes, for example, IFN-, IP-10, and RANTES. Mechanistically, these PAR 2 -mediated differential effects on TLR3 signaling were traced to changes in RIG-I and MDA-5 (reviewed in Kawai and Akira 30 ). We examined the cellular responses to TLR3 stimulation as a representative TLR-dependent antiviral pathway in mucosal ECs. Ligand-bound TLR3 activates several transcription factors, including IRF-3 and NF-B. 31 Ligand-activated TLR3 dimerizes, binds its sole adapter, TRIF, and recruits I B kinase (IKK ) and TANK-binding kinase 1 (TBK1). 32 In turn, IKK / TBK1 activates IRF-3 through C-terminal phosphorylation. The TLR3 -TRIF complex also recruits receptor-interacting protein 1 (RIP1) to couple signaling to the IKK / / complex for NF-B activation. 33 Although activated NF-B translocates to the nucleus and induces transcription of many proinflammatory cytokine or chemokine genes, for example, IL-8, MIP-3 , phosphorylated IRF-3 homodimers translocate to the nucleus to induce transcription of type I IFNs and many other IRF-3-regulated genes, for example, IFN-, IP-10, and RANTES. 34 Induction of type I IFNs is critical for evoking the expression of additional antiviral genes through the IFN-/ R / STAT1 signaling pathway. 25 -27 Both IRF-3 and NF-B are required for transcriptional activation of the potent antiviral protein, IFN-(reviewed in Kawai and Akira 30 ). Although PAR 2 AP enhanced poly I:C-induced NF-B activation, AP markedly inhibited poly I:C-driven IRF-3 activation, consistent with AP-mediated suppression of TLR3-driven IFN-mRNA expression. The inhibitory effect of AP on the TLR3 / IRF-3 signaling pathway appears to be very early, at the level of IKK / TBK1 phosphorylation of IRF-3, rather than a result of altered IRF-3 protein stability. This is further supported by the observation that poly I:C-induced, but not rIFN--induced, phosphorylation of STAT1 was inhibited by concurrent stimulation of PAR 2 by AP. The LPS-transducing receptor, TLR4, is the only other TLR that signals through the TRIF / IKK / TBK1 / IRF-3 pathway (reviewed in Akira and Takeda 8 ). In SW620 ECs, LPS-induced expression of IFNand IP-10 mRNAs was attenuated significantly by PAR 2 AP co-stimulation ( Supplementary Figure S1a online) . In A549 ECs, PAR 2 AP co-stimulation also inhibited LPS-induced IP-10 mRNA expression significantly ( Supplementary Figure S1b ) . Taken together, these data suggest that PAR 2 activation exerts a more generalized inhibitory effect on the TLR / TRIF, that is, TLR3 / TRIF and TLR4 / TRIF, signaling pathway. Consistent with previous reports attributing a positive, cooperative signaling outcome between PAR 2 and TLRs, 22 -24 we showed positive cooperativity between PAR 2 and TLRs at the level of NF-B activation. The cooperative convergence of NF-B signaling derived from these two distinct PRR families supports our contention of their proposed roles as biosensors of infection. Enhanced NF-B activation is predicted to be critical for optimal induction of inflammatory mediators, including the expression of chemokines and cytokines necessary for the recruitment and activation of circulating leukocytes to the nidus of infection. However, selective augmentation and suppression of cytokine / chemokine expression likely has an important role in the pathogenesis and persistence / clearance of a given infection. That PAR 2 activation augmented TLR3-driven expression of some chemokines, for example, IL-8 and MIP-3 , yet suppressed the expression of others, for example, IP-10 and RANTES, suggests that proteinase-rich microenvironments might drastically alter the composition of infiltrating leukocytes and, thus, significantly alter the inflammatory outcome of an infection.
Under physiological conditions, extracellular proteinases are tightly regulated by many mechanisms, including the regulation of proteinase expression and their negative control by antiproteinases. Reduced expression of anti-proteinases and / or enhanced local levels of pathogen-and / or host-derived proteinases can lead to a dysregulated proteinase / anti-proteinase balance at anatomical sites where extracellular proteolysis is undesirable (reviewed in Antalis et al. 35 ). Given that PAR 2 activation negatively regulated the TLR3 / IRF-3 antiviral pathway, we speculated that in tissues in which both PAR 2 and TLR3 are present, for example, the airway, disease processes with dysregulated and de-repressed extracellular PAR 2 -activating trypsin-like proteolytic activities might be more susceptible to infection with TLR3-triggering viruses such as influenza A. 3, 4 We confirmed this hypothesis by infecting WT C57BL / 6J and PAR 2 − / − mice with mouse-adapted H1N1 influenza A virus that can activate TLR3 and also generates extracellular proteinases that can trigger PAR 2 . In support of our in vitro observations in EC cultures, in three separate experiments, PAR 2 − / − mice were protected from challenge with influenza A virus. In contrast, IFN-− / − mice were hypersusceptible to influenza virus-induced lethality. Taken together, both the in vitro and in vivo data support our model that PAR 2 activation inhibits TLR / IRF-3 antiviral pathway; the absence of PAR 2 conferred a protective phenotype in influenza-infected mice. The absence of PAR 2 might also mitigate the NF-B-mediated cytokine storm induced by influenza infection leading, in part, to the resistance of PAR 2 − / − mice to influenza-induced lethality.
In contrast to our findings using 200 p.f.u. influenza virus per mouse, Khoufache et al. 36 mice. However, we hypothesize that different infectious doses used in the two studies (200 p.f.u. vs. 30 -60 p.f.u.) perhaps led to differential levels of PAR 2 receptor expression or activation that could potentially account for the opposite findings. The extent of tissue damage, the level of PAR 2 -activating enzymes generated, and the degree of PAR 2 receptor activation secondary to influenza infection are likely to be different at the two viral doses. In support of this hypothesis, it has been shown that differential stimulus dosage, for example, low vs. high agonist concentrations, can result in opposite biological effects. For example, Eisenbarth et al. 37 showed that low levels of LPS induced Thelper cell type 2 responses to an inhaled antigen, whereas high levels of inhaled LPS with the same antigen resulted in strong Th1 responses. The genetic backgrounds of the PAR 2 − / − mice used in the two studies were also different. The different genetargeted deletion approaches used to generate PAR 2 − / − mice and the extent of genetic backcross may also have contributed to the opposite observations. 38, 39 In addition, PAR 2 activation has been reported to exhibit opposite effects in other host inflammatory responses, 40 -43 and perhaps this is attributable to the balance of synergistic or antagonistic effects reported herein between PAR 2 and activation of other PRRs by PAMPs that are concurrently present in the environment. Future studies will be necessary to determine how differences in experimental designs might have contributed to the different findings. Nevertheless, like PAR 2 − / − mice, we observed that TLR4 − / − mice were similarly protected from H1N1 influenza A virus infection, findings that are consistent with our recently described model of PAR 2 -TLR4 receptor cooperativity. Moreover, PAR 2 AP induced footpad edema in WT C57BL / 6J mice that was absent in PAR 2 − / − mice and significantly diminished in both TLR4 − / − and MyD88 − / − mice. We also observed significantly diminished secretion of KC and MIP-2 chemokines by TLR4 − / − vs. WT C57BL / 6J colonic intestinal tissues cultured ex vivo and treated with PAR 2 AP (data not shown). Moretti et al. 18 reported recently that PAR 2 signaling in murine polymorphonuclear neutrophils depended on the presence of TLR4.
Interference of host innate antiviral defense by influenza virus is known to be achieved by the nonstructural NS1 viral protein, which dampens the induction of IRF-3-responsive antiviral genes, including IFN-. 44 However, infection of host cells by orthomyxoviruses and paramyxoviruses can also be enhanced by host / pathogen-derived proteinases 45 (and reviewed in Kido et al. 46 ). For example, co-infection with Staphylococcus aureus strains that secrete trypsin-like serine proteinases enhances influenza virus infectivity significantly by mediating cleavage of viral fusion glycoproteins, for example, hemagglutinin. 45 In this study, we have provided evidence for an additional mechanism by which host / pathogen-derived proteinases might diminish TLRmediated host antiviral response through the activation of PAR 2 . It is tempting to speculate that natural selection and host -virus co-evolution led to the utilization of proteinases for enhanced virus infectivity by simultaneously facilitating host -virus membrane fusion and interfering with host antiviral defense.
In summary, results from this study provide compelling data that suggest that regulating the extracellular proteinase / antiproteinase balance might represent an effective therapeutic approach to controlling orthomyxovirus and paramyxovirus infections. The results from this study also represent a novel example of cooperative and non-cooperative signaling integration between heterologous PRRs of the innate immune system.
METHODS
Reagents, virus, cell culture, and mice . Human PAR 2 AP, SLIGKV-NH 2 , and an inactive control RP, VKGILS-NH 2 , were synthesized (>96 % purity) by Phoenix Pharmaceuticals (Belmont, CA). Proteinfree, phenol / water-extracted LPS from Escherichia coli strain K235 was purified as referenced. 23 S-[2,3-bis(palmitoyloxy)-(2-RS)-propyl]-[R]-Cys-Ser-Lys 4 -OH (Pam2CSK4 or P2C) and poly I:C (pI:C) were purchased from Invivogen (San Diego, CA). Human rIFN-1a was purchased from PBL InterferonSource (Piscataway, NJ). Mouseadapted H1N1 influenza virus (A / PR / 8 / 34) was purchased from American Type Culture Collection (ATCC) (Manassas, VA) and grown in the allantoic fluid of 10-day old embryonated chicken eggs (Charles River Laboratories, Wilmington, MA) as previously described. 47 Human A549 lung and SW620 colonic ECs (ATCC) were propagated in Dulbecco ' s modified Eagle ' s medium (DMEM) or RPMI-1640 (CellGro, Herndon, VA), respectively. DMEM was supplemented with 10 % heatinactivated fetal calf serum (FCS; Hyclone, Logan, UT), 100 U ml − 1 penicillin, 100 g ml − 1 streptomycin, and 2 m M L -glutamine. RPMI-1640 received the same supplements, but with 2 % heat-inactivated FCS. ECs were harvested from tissue culture flasks (Corning, Corning, NY) using CellStripper solution (CellGro) and seeded in 6-well plates at 4 × 10 5 (A549) or 1 × 10 6 (SW620) cells per well. Cells were allowed to rest for 2 days with a medium change on day 1, and treated with agonists, as indicated. WT C57BL6 / J mice and PAR 2 − / − mice backcrossed onto a C57BL / 6 background (N5) were purchased from The Jackson Laboratories (Bar Harbor, ME). TLR4 − / − and MyD88 − / − mice (N у 8 on a C57BL / 6 background), originally obtained from Dr Shizuo Akira (Osaka University, Osaka, Japan), and IFN-− / − mice (N у 8 on a C57BL / 6 background), originally obtained from Dr Eleanor Fish (University of Toronto, Ontario, Canada), were bred at UMB. Mice were housed in a SPF barrier facility (UMB). Administration of AP or influenza to mice is described in the figure legends. All mice were age matched and used between 6 -10 weeks of age. All experiments were conducted with institutional approval.
Preparation of total RNA and cDNA . Total RNA from EC cultures was extracted, and oligo(dT)-primed cDNA was synthesized as previously described. 28 qPCR . Quantitative real-time PCR (qPCR) primers ( Table 1 ) were designed and synthesized as previously described. 28 qPCR was carried out on ABI Prism 7500 Fast Real-time PCR System (Applied Biosystems, Foster City, CA) in a 25 l reaction containing 20 ng cDNA, 0.3 m each of sense / anti-sense primers, and 12.5 l of Fast SYBR Green Master Mix (Applied Biosystems) under the manufacturer ' s pre-set thermal conditions: 20 s at 95 ° C, 40 cycles of 3 s at 95 ° C and 30 s at 60 ° C, followed by a dissociation stage. Relative gene expression was calculated using the 2 − Δ Δ Ct method as previously referenced, 28 with hypoxanthine guanine phosphoribosyltransferase as the housekeeping gene.
Western analysis . A549 cells were seeded at 8 × 10 5 cells per well in 6-well plates and allowed to rest for 3 days, with a medium change on day 1. After treatment, whole-cell lysates were collected, processed, resolved by gel electrophoresis, transferred to polyvinylidene difluoride membranes, probed with antibodies, and target protein bands detected as previously described. 28 Primary and horseradish peroxidase-conjugated secondary antibodies used in this study were purchased from Cell Signaling Technology (Danvers, MA) and used at 1:1,000 and 1:2,000 dilutions, respectively.
